Cargando…
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
BACKGROUND: The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented itself as one of the most important health concerns of the 2020’s, and hit the geriatric population the hardest. The presence of co-morbidities and immune ageing in the elderl...
Autores principales: | Goossens, Maria E., Neven, Kristof Y., Pannus, Pieter, Barbezange, Cyril, Thomas, Isabelle, Gucht, Steven Van, Dierick, Katelijne, Schmickler, Marie-Noëlle, Verbrugghe, Mathieu, Loon, Nele Van, Ariën, Kevin K, Marchant, Arnaud, Goriely, Stanislas, Desombere, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581120/ https://www.ncbi.nlm.nih.gov/pubmed/34763723 http://dx.doi.org/10.1186/s13690-021-00715-z |
Ejemplares similares
-
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
por: Pannus, Pieter, et al.
Publicado: (2022) -
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2
por: Triest, David, et al.
Publicado: (2021) -
Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021) -
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
por: Pannus, Pieter, et al.
Publicado: (2023) -
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients
por: Canti, Lorenzo, et al.
Publicado: (2022)